International trade · 11/05/1998

U.S. International Trade Commission Investigates Chiron Corporation's Complaint Against Recombinant Hepatitis B Vaccine Producers

The U.S. International Trade Commission has launched an investigation into Chiron Corporation's allegations that certain recombinant Hepatitis B vaccine producers are violating U.S. patent laws by importing and selling their products in the United States